ANI
TEVA icon

American National Insurance’s Teva Pharmaceuticals TEVA Stock Holding History

American National Insurance’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,325
Closed -$287K – 353
2017
Q3 		$287K Hold
16,325
– – 0.02% 332
2017
Q2 		$542K Hold
16,325
– – 0.03% 288
2017
Q1 		$524K Hold
16,325
– – 0.03% 294
2016
Q4 		$592K Hold
16,325
– – 0.03% 269
2016
Q3 		$751K Hold
16,325
– – 0.04% 278
2016
Q2 		$820K Hold
16,325
– – 0.05% 266
2016
Q1 		$874K Hold
16,325
– – 0.05% 265
2015
Q4 		$1.07M Hold
16,325
– – 0.06% 253
2015
Q3 		$922K Hold
16,325
– – 0.06% 249
2015
Q2 		$965K Hold
16,325
– – 0.06% 251
2015
Q1 		$1.02M Hold
16,325
– – 0.06% 245
2014
Q4 		$939K Hold
16,325
– – 0.06% 251
2014
Q3 		$877K Hold
16,325
– – 0.05% 260
2014
Q2 		$856K Hold
16,325
– – 0.05% 258
2014
Q1 		$863K Hold
16,325
– – 0.06% 255
2013
Q4 		$654K Hold
16,325
– – 0.04% 274
2013
Q3 		$617K Hold
16,325
– – 0.04% 275
2013
Q2 		$640K Buy
+16,325
New +$636K 0.05% 266

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

American National Insurance's TEVA Position: Q4 2017 in Review

American National Insurance sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 16,325 shares — an estimated $287K sold.

American National Insurance first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $1.07M in Q4 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • American National Insurance reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • American National Insurance sold 16,325 Teva Pharmaceuticals shares in Q4 2017, an estimated $287K.
  • American National Insurance first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • American National Insurance's Teva Pharmaceuticals position peaked at $1.07M in Q4 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on American National Insurance's 13F filing for Q4 2017, filed 14 Feb 2018.